Melatonin and agomelatine for preventing seasonal affective disorder

Angela Kaminski-Hartenthaler, Barbara Nussbaumer, Catherine A. Forneris, Laura C. Morgan, Bradley N. Gaynes, Jeffrey H. Sonis, Amy Greenblatt, Jörg Wipplinger, Linda J. Lux, Julia Hofmann, Megan G. Van Noord, Dietmar Winkler, Gerald Gartlehner

Research output: Contribution to journalArticle

10 Scopus citations

Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the efficacy and safety of melatonin and agomelatine to prevent SAD and improve patient-centred outcomes in adults with a history of SAD.

Original languageEnglish (US)
Article numberCD011271
JournalCochrane Database of Systematic Reviews
Volume2014
Issue number9
DOIs
StatePublished - Sep 2 2014
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Kaminski-Hartenthaler, A., Nussbaumer, B., Forneris, C. A., Morgan, L. C., Gaynes, B. N., Sonis, J. H., Greenblatt, A., Wipplinger, J., Lux, L. J., Hofmann, J., Van Noord, M. G., Winkler, D., & Gartlehner, G. (2014). Melatonin and agomelatine for preventing seasonal affective disorder. Cochrane Database of Systematic Reviews, 2014(9), [CD011271]. https://doi.org/10.1002/14651858.CD011271